Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2013 077 452.8 |
96 | EP file number | EAKZ | 13 72 5885.1 |
86 | WO file number | WAKZ | PCT/US2013/042104 |
97 | EP publication number | EPN | 2852603 |
87 | WO publication number | WPN | 2013177219 |
54 | Designation/title | TI | D-AMINOSÄURE-VERBINDUNGEN GEGEN LEBERERKRANKUNGEN |
51 | IPC main class | ICM (ICMV) | C07H 19/10 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07H 19/20 (2006.01), A61K 31/7056 (2006.01), A61K 31/7072 (2006.01), A61K 31/7076 (2006.01), A61K 31/708 (2006.01), A61P 1/16 (2006.01), A61P 31/14 (2006.01) |
22 | DE application date | DAT | May 21, 2013 |
96 | EP application date | EAT | May 21, 2013 |
86 | WO application date | WAT | May 21, 2013 |
43 | Date of first publication | OT | Nov 28, 2013 |
| Date of publication of grant | PET | May 12, 2021 |
71/73 | Applicant/owner | INH | Idenix Pharmaceuticals LLC, Cambridge, Mass., US |
72 | Inventor | IN | MAYES, Benjamin Alexander, Boston, Massachusetts 02122, US; STEWART, Alistair James, Lincoln, Massachusetts 01773, US; MOUSSA, Adel M., Burlington, Massachusetts 01803, US |
74 | Representative | VTR | Venner Shipley Germany LLP, 81669 München, DE |
| Address for service | | Venner Shipley Germany LLP, 81669 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361807268 P Apr 1, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261726521 P Nov 14, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261650414 P May 22, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361807266 P Apr 1, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261739509 P Dec 19, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361807249 P Apr 1, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261726522 P Nov 14, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261716874 P Oct 22, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261711131 P Oct 8, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361772325 P Mar 4, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361792131 P Mar 15, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261695218 P Aug 30, 2012
|
| Due date | FT FG | May 31, 2026 Annual fee for the 14th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002852603 Searchable text:
EP000002852603 Original document:
EP000002852603B1 Searchable text:
EP000002852603B1 Original document:
WO002013177219 Searchable text:
WO002013177219 |
43 | Date of first publication | EVT | Nov 28, 2013 |
| Date of the first transfer into DPMAregister | EREGT | Apr 2, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 15, 2025 (Show all update days)(Hide all update days)- Apr 15, 2025
- Due date: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 12.05.2021: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 12.05.2021: deleted
- Sep 19, 2024
- St.36: changed (technical change)
- Jun 8, 2024; May 9, 2024; Apr 17, 2024; Apr 21, 2023; Nov 19, 2022; Nov 18, 2022; Sep 7, 2022; Sep 6, 2022; Apr 15, 2022; Apr 14, 2022; Mar 31, 2022; Jun 25, 2021; Jun 2, 2021; Apr 23, 2021; Apr 22, 2021; Oct 8, 2020
- Historical data not available for this/these date(s)
- Apr 2, 2015
- Date of the first transfer into DPMAregister
|